We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
7 result(s) found, displaying 1 to 7
-
Australian Public Assessment Report (AusPAR)Erwinase (crisantaspase) has been approved for the treatment of acute lymphoblastic leukemia (ALL) as a component of a multi-agent chemotherapeutic regimen for patients who have developed hypersensitivity to pegylated asparaginase.
-
Prescription medicine decision summaryErwinase (crisantaspase) has been approved as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegylated asparaginase obtained from E. coli.
-
Prescription medicine registrationActive ingredients: crisantaspase.
-
Australian Public Assessment Report (AusPAR)Nuceiva (prabotulinum toxin A) is indicated for the temporary improvement in appearance of glabellar lines.
-
Prescription medicine decision summaryNuceiva (prabotulinumtoxinA) is approved to treat glabellar lines.
-
Prescription medicine registrationActive ingredients: prabotulinumtoxinA.
-